Qsymia
Definition
An oral once-daily combination of phentermine + topiramate extended-release at four dose strengths (3.75/23 to 15/92 mg). FDA-approved July 2012 for chronic weight management. EQUIP trial showed -10.9% body weight at 56 weeks. Requires a REMS contraception program due to topiramate teratogenicity risk.
Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.
Related terms in drug
Looking for more depth?
- Qsymia drug page
- Browse the full GLP-1 glossary (124 terms across 8 categories)
- Research articles — primary-source deep dives
- Tools and calculators
- Compare GLP-1 telehealth providers